EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS). Subjects. Twenty-seven patients with progressive and measurable disease were treated. Median age was 53 years (range 20–71...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizer, H. Jan, Crowther, Derek, Nielsen, Ole Steen, Oosterom, Allan T. Van, Muguiro, Javier Hornedo, Pottelberghe, Christine Van, Somers, Renier, Tursz, Thomas
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395351/
https://www.ncbi.nlm.nih.gov/pubmed/18521209
http://dx.doi.org/10.1080/13577149778371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395351/
https://www.ncbi.nlm.nih.gov/pubmed/18521209
http://dx.doi.org/10.1080/13577149778371

Ejemplares similares